Part number: MN-1237-G
Image is representative (may not be specific item).
Download: Instructions for use - hemaPEN [PDF]
Also see: Video - Instructional video for hemaPEN use
This information is relevant for hemaPEN supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only. For research use, please click here.
ARTG number: 280007, US FDA number: D410490
Collections: All, hemaPEN, hemaPEN (all), Instructions for use, Literature - All, Literature - Health, Microsampling, Sampling, Support Items
Category: ARTG, ARTG 280007, Australia, Australian Register of Therapeutic Goods, Blood, CE mark, Class I, Clinical, DBS, EU, FDA, Health, hemaPEN, Histology, IFU, IVD, Life, Microsampling, New Zealand, Pathology, Research, Sample collection, Sampling, Support, TGA, Therapeutic Goods Administration, UK, US FDA, US FDA D410490, USA
Type: Instructions for use
Download: Advanced precision microsampling for COVID-19 research [PDF]
This information is relevant for hemaPEN supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only. For research use, please click here.
ARTG number: 280007, US FDA number: D410490
View full product details
Download: Application Note - Analysis of 15 organic acids [PDF]
Download: Application Note - Analysis of 16 synthetic pyrethroids [PDF]
Download: Application Note - Analysis of 16 synthetic pyrethroids [PDF]
Privacy and security | Terms and conditions
© 2021 Trajan Scientific and Medical.
Trajan Scientific Australia Pty Ltd.